AZN.UK

10,194

+0.14%↑

INDV

825.5

-0.48%↓

AZN.UK

10,194

+0.14%↑

INDV

825.5

-0.48%↓

AZN.UK

10,194

+0.14%↑

INDV

825.5

-0.48%↓

AZN.UK

10,194

+0.14%↑

INDV

825.5

-0.48%↓

AZN.UK

10,194

+0.14%↑

INDV

825.5

-0.48%↓

Search

GlaxoSmithKline PLC

Fermé

SecteurSoins de santé

1,375.5 0.7

Résumé

Variation du prix de l'action

24h

Actuel

Min

1373

Max

1377.5

Chiffres clés

By Trading Economics

Revenu

1.3B

1.8B

Ventes

-601M

7.5B

P/E

Moyenne du Secteur

19.059

54.379

BPA

44.9

Rendement du dividende

4.42

Marge bénéficiaire

23.576

Employés

68,629

EBITDA

2B

3.1B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+1.96% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.42%

2.55%

Prochains Résultats

30 juil. 2025

Date du Prochain Dividende

10 juil. 2025

Date du Prochain Détachement de Dividende

15 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

2.4B

59B

Ouverture précédente

1374.8

Clôture précédente

1375.5

Sentiment de l'Actualité

By Acuity

53%

47%

170 / 382 Classement par Healthcare

GlaxoSmithKline PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

30 avr. 2025, 07:03 UTC

Résultats

GSK Sales, Profit Rise on Boost from HIV, Cancer Drugs -- Update

30 avr. 2025, 06:37 UTC

Résultats

GSK Sales, Profit Rise on Boost from Cancer Drugs

9 avr. 2025, 09:39 UTC

Principaux Mouvements du Marché

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

30 avr. 2025, 08:54 UTC

Market Talk
Résultats

GSK Investors Turn to U.S. Policy Outlook After Solid Results -- Market Talk

30 avr. 2025, 07:49 UTC

Market Talk
Résultats

GSK's Specialty Meds Sustain Growth, Blenrep Comeback Remains Key -- Market Talk

30 avr. 2025, 07:06 UTC

Market Talk
Résultats

GSK Outperforms Expectations Despite RSV Vaccine Setback -- Market Talk

30 avr. 2025, 06:03 UTC

Résultats

GSK: Confident in Long-Term Outlook

30 avr. 2025, 06:03 UTC

Résultats

GSK Declares Dividend of 16p Vs 15p

30 avr. 2025, 06:02 UTC

Résultats

GSK 1Q Core EPS 44.9p

30 avr. 2025, 06:02 UTC

Résultats

GSK 1Q Core Operating Profit GBP2.53B

30 avr. 2025, 06:02 UTC

Résultats

GSK 1Q Net Pft GBP1.62B

30 avr. 2025, 06:01 UTC

Résultats

GSK Backs 2025 View

30 avr. 2025, 06:00 UTC

Résultats

Analysts Saw GSK PLC 1Q Net Profit at GBP1.67B

30 avr. 2025, 06:00 UTC

Résultats

Analysts Saw GSK PLC 1Q Turnover at GBP7.42B

30 avr. 2025, 06:00 UTC

Résultats

GSK PLC 1Q EPS 39.3p

30 avr. 2025, 06:00 UTC

Résultats

GSK PLC 1Q Adj EPS 44.9p

30 avr. 2025, 06:00 UTC

Résultats

GSK PLC 1Q Pre-items, Pretax Pft GBP2.43B

30 avr. 2025, 06:00 UTC

Résultats

GSK PLC 1Q Oper Pft GBP2.22B

30 avr. 2025, 06:00 UTC

Résultats

GSK PLC 1Q Net Pft GBP1.62B

30 avr. 2025, 06:00 UTC

Résultats

GSK PLC 1Q Pretax Pft GBP2.11B

23 avr. 2025, 21:48 UTC

Actualités

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

23 avr. 2025, 20:47 UTC

Actualités

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

23 avr. 2025, 20:40 UTC

Actualités

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

15 avr. 2025, 09:55 UTC

Market Talk

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9 avr. 2025, 07:23 UTC

Market Talk

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3 avr. 2025, 08:41 UTC

Market Talk

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3 avr. 2025, 08:36 UTC

Market Talk

U.K. Pharma to Have Some Share-Price Volatility But Long-Term Outlook Remains Intact -- Market Talk

3 avr. 2025, 07:51 UTC

Market Talk

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

2 avr. 2025, 09:27 UTC

Actions en Tendance

Stocks to Watch Wednesday: Tesla, Newsmax, Novo Nordisk -- WSJ

26 mars 2025, 22:29 UTC

Actualités

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- 2nd Update

Comparaison

Variation de prix

GlaxoSmithKline PLC prévision

Objectif de Prix

By TipRanks

1.96% hausse

Prévisions sur 12 Mois

Moyen 1,404.46 GBX  1.96%

Haut 2,290 GBX

Bas 13.55 GBX

Basé sur 13 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

13 ratings

2

Achat

7

Maintien

4

Vente

Sentiment

By Acuity

170 / 382Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.